CN Stock MarketDetailed Quotes

600518 Kangmei Pharmaceutical

Watchlist
  • 1.76
  • 0.000.00%
Market Closed Sep 10 15:00 CST
24.40BMarket Cap97.78P/E (TTM)

Kangmei Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
4.09%2.47B
5.01%1.2B
16.60%4.87B
29.84%3.53B
33.62%2.38B
22.50%1.14B
0.67%4.18B
-11.80%2.72B
-14.04%1.78B
-14.15%933.85M
Operating revenue
4.09%2.47B
5.01%1.2B
16.60%4.87B
29.84%3.53B
33.62%2.38B
22.50%1.14B
0.67%4.18B
-11.80%2.72B
-14.04%1.78B
-14.15%933.85M
Other operating revenue
-32.01%16.7M
----
149.66%47.3M
----
110.39%24.56M
----
-80.82%18.95M
----
-81.54%11.67M
----
Total operating cost
0.52%2.59B
3.28%1.27B
0.10%4.89B
26.48%3.84B
30.25%2.58B
17.79%1.23B
-25.00%4.89B
-30.20%3.03B
-38.44%1.98B
-38.82%1.04B
Operating cost
7.79%2.11B
4.58%1.03B
13.96%4.04B
29.95%2.94B
32.15%1.96B
23.59%982.88M
1.75%3.55B
-10.13%2.26B
-11.85%1.48B
-7.96%795.28M
Operating tax surcharges
-46.55%22.26M
-12.96%11.19M
-240.45%-274.18M
309.03%53.98M
56.77%41.64M
-1.91%12.85M
-70.13%195.22M
-72.57%13.2M
-16.95%26.56M
-25.13%13.1M
Operating expense
-37.96%191.81M
-7.72%95.76M
18.24%551.78M
47.21%437.36M
66.86%309.16M
18.46%103.77M
3.74%466.64M
-13.11%297.11M
-25.56%185.28M
-32.94%87.6M
Administration expense
-3.78%244.84M
0.38%126.37M
-18.29%502.12M
-17.11%384.72M
-11.35%254.45M
-17.03%125.9M
-28.24%614.49M
-15.40%464.16M
-21.68%287.04M
-21.23%151.73M
Financial expense
85.71%-1.27M
81.87%-821.58K
-33.59%27.12M
32.18%-13.68M
34.80%-8.92M
36.08%-4.53M
-96.16%40.84M
-102.29%-20.18M
-101.56%-13.69M
-101.42%-7.09M
-Interest expense (Financial expense)
-2.67%6.09M
-0.54%2.99M
-28.83%56.15M
18.79%9.37M
22.13%6.26M
17.73%3M
-92.28%78.9M
-99.06%7.89M
-99.39%5.12M
-99.49%2.55M
-Interest Income (Financial expense)
51.96%-7.84M
48.69%-4.03M
23.19%-30.74M
17.43%-24.54M
18.62%-16.33M
20.79%-7.86M
-659.36%-40.03M
-1,301.73%-29.73M
-1,503.53%-20.06M
-1,650.53%-9.92M
Research and development
-3.36%22.79M
9.23%10.36M
79.27%45.62M
95.81%37.84M
91.72%23.58M
141.65%9.49M
174.41%25.45M
70.48%19.33M
44.01%12.3M
-6.90%3.93M
Credit Impairment Loss
560.66%48.91M
46,711.60%13.58M
188.87%202.17M
1,731.73%66.71M
124.81%7.4M
99.78%-29.13K
89.59%-227.48M
85.40%-4.09M
-0.40%-29.83M
-393.08%-13.29M
Asset Impairment Loss
-163.50%-467.4K
-99.54%1.59K
60.26%-197.55M
482.85%782.69K
225.72%736.11K
91.34%348.36K
84.43%-497.16M
-117.67%-204.44K
25.39%-585.5K
-85.02%182.06K
Other net revenue
59.33%138.37M
121.35%79.11M
110.04%107.27M
1,060.31%162.63M
901.60%86.85M
1,071.37%35.74M
-108.56%-1.07B
-94.51%14.02M
-104.46%-10.83M
-120.00%-3.68M
Fair value change income
42.44%-10.04K
---5.26K
---34.51K
---25.85K
---17.45K
----
----
----
----
----
Invest income
91.10%41.8M
412.09%29.53M
5,849.29%44.43M
24,761.53%33.31M
285,176.16%21.87M
95,704.45%5.77M
-99.60%746.87K
-99.92%133.97K
-100.00%7.67K
--6.02K
Asset deal income
39.23%28.36M
29.59%26.13M
1,902.41%19.61M
3,026.64%20.46M
3,694.12%20.37M
6,459.68%20.16M
-98.47%979.19K
-98.59%654.34K
-98.85%536.9K
-88.35%307.36K
Other revenue
-45.78%19.78M
4.10%9.88M
111.20%38.65M
136.28%41.4M
91.62%36.48M
4.15%9.49M
-101.96%-344.99M
-69.73%17.52M
-60.87%19.04M
-8.91%9.11M
Operating profit
115.47%18.16M
118.92%9.59M
104.88%86.67M
53.14%-139.12M
45.07%-117.36M
55.70%-50.67M
-117.58%-1.78B
70.42%-296.89M
76.45%-213.67M
80.97%-114.39M
Add:Non operating Income
-47.88%9.1M
-92.15%583.5K
81.67%57.88M
-21.95%22.56M
-34.56%17.45M
288.51%7.43M
30.42%31.86M
307.34%28.9M
748.22%26.67M
8.10%1.91M
Less:Non operating expense
-84.35%2.43M
-52.19%508.1K
-96.28%34.18M
-97.37%15.99M
161.22%15.56M
65.97%1.06M
-53.62%918.37M
32,945.70%608.74M
411.66%5.96M
299.53%640.38K
Total profit
121.49%24.82M
121.82%9.66M
104.14%110.37M
84.88%-132.55M
40.16%-115.47M
60.83%-44.3M
-132.67%-2.66B
12.19%-876.73M
78.68%-192.96M
81.14%-113.11M
Less:Income tax cost
-30.20%6.7M
-80.75%1.05M
-77.14%6.8M
68.18%13.99M
275.97%9.59M
451.13%5.46M
-87.36%29.75M
-70.88%8.32M
-90.70%2.55M
43.89%-1.56M
Net profit
FLtoP18.12M
FLtoP8.61M
FLtoP103.57M
FPtoL-146.54M
FPtoL-125.06M
FPtoL-49.77M
SL-2.69B
FPtoL-885.05M
FPtoL-195.51M
FPtoL-111.56M
Net profit from continuing operation
114.49%18.12M
117.31%8.61M
103.84%103.57M
83.44%-146.54M
36.03%-125.06M
55.39%-49.77M
-134.01%-2.69B
13.83%-885.05M
79.04%-195.51M
81.31%-111.56M
Less:Minority Profit
197.51%2.36M
77.48%1.14M
118.54%1.05M
103.32%1.47M
488.60%793.21K
575.89%643.19K
-381.56%-5.64M
129.44%723.15K
104.29%134.76K
91.52%-135.15K
Net profit of parent company owners
112.52%15.76M
114.82%7.47M
103.81%102.52M
83.29%-148.01M
35.67%-125.86M
54.76%-50.41M
-133.95%-2.69B
13.55%-885.77M
78.95%-195.65M
81.28%-111.42M
Earning per share
Basic earning per share
111.11%0.001
125.00%0.001
105.26%0.01
82.81%-0.011
35.71%-0.009
50.00%-0.004
-133.33%-0.19
13.51%-0.064
79.10%-0.014
93.39%-0.008
Diluted earning per share
111.11%0.001
125.00%0.001
105.26%0.01
82.81%-0.011
35.71%-0.009
50.00%-0.004
-133.33%-0.19
13.51%-0.064
79.10%-0.014
93.39%-0.008
Other composite income
-1,878.74%-151.92K
-3,977.41%-21.77K
-158.78%-235.82K
-556.27%-13.4K
238.16%8.54K
-533.98
-88.44%401.22K
-98.10%2.94K
-98.41%2.53K
Other composite income of parent company owners
-1,878.74%-151.92K
-3,977.41%-21.77K
-158.78%-235.82K
-556.27%-13.4K
238.16%8.54K
---533.98
-88.44%401.22K
-98.10%2.94K
-98.41%2.53K
----
Total composite income
114.37%17.97M
117.26%8.59M
103.84%103.33M
83.44%-146.55M
36.04%-125.06M
55.39%-49.77M
-133.99%-2.69B
13.81%-885.04M
79.03%-195.51M
81.30%-111.56M
Total composite income of parent company owners
112.40%15.61M
114.78%7.45M
103.81%102.29M
83.29%-148.02M
35.67%-125.85M
54.76%-50.41M
-133.93%-2.69B
13.54%-885.77M
78.95%-195.64M
81.28%-111.42M
Total composite income of minority owners
197.51%2.36M
77.48%1.14M
118.54%1.05M
103.32%1.47M
488.60%793.21K
575.89%643.19K
-381.56%-5.64M
129.44%723.15K
104.29%134.76K
91.52%-135.15K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 4.09%2.47B5.01%1.2B16.60%4.87B29.84%3.53B33.62%2.38B22.50%1.14B0.67%4.18B-11.80%2.72B-14.04%1.78B-14.15%933.85M
Operating revenue 4.09%2.47B5.01%1.2B16.60%4.87B29.84%3.53B33.62%2.38B22.50%1.14B0.67%4.18B-11.80%2.72B-14.04%1.78B-14.15%933.85M
Other operating revenue -32.01%16.7M----149.66%47.3M----110.39%24.56M-----80.82%18.95M-----81.54%11.67M----
Total operating cost 0.52%2.59B3.28%1.27B0.10%4.89B26.48%3.84B30.25%2.58B17.79%1.23B-25.00%4.89B-30.20%3.03B-38.44%1.98B-38.82%1.04B
Operating cost 7.79%2.11B4.58%1.03B13.96%4.04B29.95%2.94B32.15%1.96B23.59%982.88M1.75%3.55B-10.13%2.26B-11.85%1.48B-7.96%795.28M
Operating tax surcharges -46.55%22.26M-12.96%11.19M-240.45%-274.18M309.03%53.98M56.77%41.64M-1.91%12.85M-70.13%195.22M-72.57%13.2M-16.95%26.56M-25.13%13.1M
Operating expense -37.96%191.81M-7.72%95.76M18.24%551.78M47.21%437.36M66.86%309.16M18.46%103.77M3.74%466.64M-13.11%297.11M-25.56%185.28M-32.94%87.6M
Administration expense -3.78%244.84M0.38%126.37M-18.29%502.12M-17.11%384.72M-11.35%254.45M-17.03%125.9M-28.24%614.49M-15.40%464.16M-21.68%287.04M-21.23%151.73M
Financial expense 85.71%-1.27M81.87%-821.58K-33.59%27.12M32.18%-13.68M34.80%-8.92M36.08%-4.53M-96.16%40.84M-102.29%-20.18M-101.56%-13.69M-101.42%-7.09M
-Interest expense (Financial expense) -2.67%6.09M-0.54%2.99M-28.83%56.15M18.79%9.37M22.13%6.26M17.73%3M-92.28%78.9M-99.06%7.89M-99.39%5.12M-99.49%2.55M
-Interest Income (Financial expense) 51.96%-7.84M48.69%-4.03M23.19%-30.74M17.43%-24.54M18.62%-16.33M20.79%-7.86M-659.36%-40.03M-1,301.73%-29.73M-1,503.53%-20.06M-1,650.53%-9.92M
Research and development -3.36%22.79M9.23%10.36M79.27%45.62M95.81%37.84M91.72%23.58M141.65%9.49M174.41%25.45M70.48%19.33M44.01%12.3M-6.90%3.93M
Credit Impairment Loss 560.66%48.91M46,711.60%13.58M188.87%202.17M1,731.73%66.71M124.81%7.4M99.78%-29.13K89.59%-227.48M85.40%-4.09M-0.40%-29.83M-393.08%-13.29M
Asset Impairment Loss -163.50%-467.4K-99.54%1.59K60.26%-197.55M482.85%782.69K225.72%736.11K91.34%348.36K84.43%-497.16M-117.67%-204.44K25.39%-585.5K-85.02%182.06K
Other net revenue 59.33%138.37M121.35%79.11M110.04%107.27M1,060.31%162.63M901.60%86.85M1,071.37%35.74M-108.56%-1.07B-94.51%14.02M-104.46%-10.83M-120.00%-3.68M
Fair value change income 42.44%-10.04K---5.26K---34.51K---25.85K---17.45K--------------------
Invest income 91.10%41.8M412.09%29.53M5,849.29%44.43M24,761.53%33.31M285,176.16%21.87M95,704.45%5.77M-99.60%746.87K-99.92%133.97K-100.00%7.67K--6.02K
Asset deal income 39.23%28.36M29.59%26.13M1,902.41%19.61M3,026.64%20.46M3,694.12%20.37M6,459.68%20.16M-98.47%979.19K-98.59%654.34K-98.85%536.9K-88.35%307.36K
Other revenue -45.78%19.78M4.10%9.88M111.20%38.65M136.28%41.4M91.62%36.48M4.15%9.49M-101.96%-344.99M-69.73%17.52M-60.87%19.04M-8.91%9.11M
Operating profit 115.47%18.16M118.92%9.59M104.88%86.67M53.14%-139.12M45.07%-117.36M55.70%-50.67M-117.58%-1.78B70.42%-296.89M76.45%-213.67M80.97%-114.39M
Add:Non operating Income -47.88%9.1M-92.15%583.5K81.67%57.88M-21.95%22.56M-34.56%17.45M288.51%7.43M30.42%31.86M307.34%28.9M748.22%26.67M8.10%1.91M
Less:Non operating expense -84.35%2.43M-52.19%508.1K-96.28%34.18M-97.37%15.99M161.22%15.56M65.97%1.06M-53.62%918.37M32,945.70%608.74M411.66%5.96M299.53%640.38K
Total profit 121.49%24.82M121.82%9.66M104.14%110.37M84.88%-132.55M40.16%-115.47M60.83%-44.3M-132.67%-2.66B12.19%-876.73M78.68%-192.96M81.14%-113.11M
Less:Income tax cost -30.20%6.7M-80.75%1.05M-77.14%6.8M68.18%13.99M275.97%9.59M451.13%5.46M-87.36%29.75M-70.88%8.32M-90.70%2.55M43.89%-1.56M
Net profit FLtoP18.12MFLtoP8.61MFLtoP103.57MFPtoL-146.54MFPtoL-125.06MFPtoL-49.77MSL-2.69BFPtoL-885.05MFPtoL-195.51MFPtoL-111.56M
Net profit from continuing operation 114.49%18.12M117.31%8.61M103.84%103.57M83.44%-146.54M36.03%-125.06M55.39%-49.77M-134.01%-2.69B13.83%-885.05M79.04%-195.51M81.31%-111.56M
Less:Minority Profit 197.51%2.36M77.48%1.14M118.54%1.05M103.32%1.47M488.60%793.21K575.89%643.19K-381.56%-5.64M129.44%723.15K104.29%134.76K91.52%-135.15K
Net profit of parent company owners 112.52%15.76M114.82%7.47M103.81%102.52M83.29%-148.01M35.67%-125.86M54.76%-50.41M-133.95%-2.69B13.55%-885.77M78.95%-195.65M81.28%-111.42M
Earning per share
Basic earning per share 111.11%0.001125.00%0.001105.26%0.0182.81%-0.01135.71%-0.00950.00%-0.004-133.33%-0.1913.51%-0.06479.10%-0.01493.39%-0.008
Diluted earning per share 111.11%0.001125.00%0.001105.26%0.0182.81%-0.01135.71%-0.00950.00%-0.004-133.33%-0.1913.51%-0.06479.10%-0.01493.39%-0.008
Other composite income -1,878.74%-151.92K-3,977.41%-21.77K-158.78%-235.82K-556.27%-13.4K238.16%8.54K-533.98-88.44%401.22K-98.10%2.94K-98.41%2.53K
Other composite income of parent company owners -1,878.74%-151.92K-3,977.41%-21.77K-158.78%-235.82K-556.27%-13.4K238.16%8.54K---533.98-88.44%401.22K-98.10%2.94K-98.41%2.53K----
Total composite income 114.37%17.97M117.26%8.59M103.84%103.33M83.44%-146.55M36.04%-125.06M55.39%-49.77M-133.99%-2.69B13.81%-885.04M79.03%-195.51M81.30%-111.56M
Total composite income of parent company owners 112.40%15.61M114.78%7.45M103.81%102.29M83.29%-148.02M35.67%-125.85M54.76%-50.41M-133.93%-2.69B13.54%-885.77M78.95%-195.64M81.28%-111.42M
Total composite income of minority owners 197.51%2.36M77.48%1.14M118.54%1.05M103.32%1.47M488.60%793.21K575.89%643.19K-381.56%-5.64M129.44%723.15K104.29%134.76K91.52%-135.15K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianzhu International Accounting Firm (Special General Partnership)------Tianzhu International Accounting Firm (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg